A Study of JNJ-70033093 and Digoxin in Healthy Participants

NCT04206488 ↗

Phase 1 Completed 30 enrolled Janssen Research & Development, LLC Bristol-Myers Squibb · collab

NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to evaluate the potential pharmacokinetic (PK) interaction between JNJ-70033093 and digoxin in healthy participants after single dose administration and at steady state.

Timeline

Start: 2020-01-09
Primary completion: 2021-06-09
Completion: 2021-06-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Digoxin	Other / unclassified	—	Oral
Subject	Milvexian	Small molecule	—	Oral

Indications

No indication recorded.